Psilocybin prevents chemotherapy nerve damage in mice
Reported byNature Journal ↗·Sourced by Goodlede
Psilocybin, the psychoactive compound in magic mushrooms, completely prevented mice from developing chemotherapy-induced peripheral neuropathy when given two doses before cancer treatment, a condition that affects up to 60% of people treated with platinum-based drugs.
Findings are from mouse models; clinical translation in humans will require further research and testing.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at Nature Journal
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede